Cramer says snap up this leading medtech stock — wishes he could buy shares too

Cramer says snap up this leading medtech stock — wishes he could buy shares too


GE Healthcare booth is seen ahead of the 2022 China International Fair for Trade in Services (CIFTIS) at China National Convention Center on August 28, 2022 in Beijing, China. 

Yi Haifei | China News Service | Getty Images

GE Healthcare (GEHC) shares are sliding Thursday, giving Club members an opportunity to invest in the medical-technology company at an increasingly attractive valuation. The sellers Thursday are making a mistake, and we would capitalize on their misjudgment if not for restrictions that prevent us from trading the stock.



Source

Walgreens tops quarterly revenue estimates, but narrows profit outlook in 'challenging' economy
Health

Walgreens tops quarterly revenue estimates, but narrows profit outlook in 'challenging' economy

A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021.  Andrew Kelly | Reuters Walgreens on Thursday reported fiscal second-quarter sales that beat Wall Street’s expectations, but lowered the high end of its full-year adjusted earnings outlook in part due to a […]

Read More
Sexually transmitted infection rates have risen sharply among adults 55 and older, CDC data shows
Health

Sexually transmitted infection rates have risen sharply among adults 55 and older, CDC data shows

Sexually transmitted infections are becoming more common in older adults. Rates of chlamydia, gonorrhea and syphilis in people ages 55 and up more than doubled in the U.S. over the 10-year period from 2012 to 2022, according to data from the Centers for Disease Control and Prevention. The number of syphilis cases among people ages 55 and […]

Read More
Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
Health

Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart

Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a midstage trial, a finding that could set it apart in a potentially crowded market. Altimmune is one of several smaller biotech companies that are pushing to compete directly with Novo Nordisk and Eli Lilly […]

Read More